The role of tubulointerstitial injury in chronic renal failure

Current Opinion in Nephrology and Hypertension

Volumn 9, Issue 2, 2000, Pages 133-138

  Becker, Gavin J ^a   Hewitson, Tim D ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIOSCLEROSIS; CHRONIC KIDNEY FAILURE; FIBROBLAST; GLOMERULOSCLEROSIS; HUMAN; KIDNEY FIBROSIS; KIDNEY FUNCTION; PRIORITY JOURNAL; REVIEW;

DISEASE PROGRESSION; FIBROBLASTS; FIBROSIS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TUBULES;

EID: 0034014671     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200003000-00006     Document Type: Review

References (66)

1. 1 Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992; 20:1-17.
2. 2 Norman JT, Fine LG. Progressive renal disease: fibroblasts, extracellular matrix, and integrins. Exp Nephrol 1999; 7:167-177. A recent review on the role of fibroblasts and integrins in fibrogenesis.
3. 3 Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 1998; 339:1448-1456. A review integrating the theories of glomerular and interstitial sclerosis.
4. 4 Gilbert RE, Cooper ME. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int 1999; 56:1627-1637.
5. 5 Healy E, Brady HR. Role of tubule epithelial cells in the pathogenesis of tubulointerstitial fibrosis induced by glomerular disease. Curr Opin Nephrol Hypertens 1998; 7:525-530.
6. 6 Fine LG, Orphanides C, Norman JT. Progressive renal disease: the chronic hypoxia hypothesis. Kidney Int 1998; 53 (Suppl. 65):S74-S78.
7. 7 Thomas SE, Anderson S, Gordon KL, Oyama TT, Shankland SJ, Johnson RJ. Tubulointerstitial disease in aging: evidence for underlying peritubular capillary damage, a potential role for renal ischemia. J Am Soc Nephrol 1998; 9:231-242.
8. 8 Schrier RW, Harris DCH, Chan L, Shapiro JI, Caramelo C. Tubular hypermetabolism as a factor in the progression of chronic renal failure. Am J Kidney Dis 1988; 12:243-249.
9. 9 Wang S-N, LaPage J, Hirschberg R. Glomerular ultrafiltration and apical action of IGF-I, TGF-beta and HGF in nephrotic syndrome. Kidney Int 1999; 56:1247-1251.
10. 10 Nath KA, Grande JP, Croatt AJ, Likely S, Hebbel RP, Enright H. Intracellular targets in heme protein-induced renal injury. Kidney Int 1998; 53:100-111. A paper describing heme-induced tubular injury, which may be relevant to chronic haematuric diseases such as IgA nephropathy.
11. 11 Johnson DW, Saunders HJ, Baxter RC, Field MJ, Pollock CA. Paracrine stimulation of human renal fibroblasts by proximal tubule cells. Kidney Int 1998; 54:747-757. This study examines the bidirectional signals between cultured human tubular epithelial cells and fibroblasts. Such signals may elicit and perpetuate fibrogenesis.
12. 12 Nath KA. The tubulointerstitium in progressive renal disease. Kidney Int 1998; 54:992-994.
13. 13 Basile DP. The transforming growth factor beta system in kidney disease and repair: recent progress and future directions. Curr Opin Nephrol Hypertens 1999; 8:21-30.
14. 14 Wardle EN. Renal collagen synthesis and its control. Nephron 1999; 83:106-110.
15. 2(V) collagen by TGF-β1 in tubulointerstitial cell models. Nephrol Dial Transplant 1998; 13:573-579.
16. 16 Hugo C, Shankland SJ, Pichler RH, Couser WG, Johnson RJ. Thrombospondin 1 precedes and predicts the development of tubulointerstitial fibrosis in glomerular disease in the rat. Kidney Int 1998; 53:302-311.
17. 17 Duncan MR, Frazier KS, Abramson S, Williams S, Klapper H, Huang X, Grotendorst GR. Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: downregulation by cAMP. FASEB J 1999; 13:1774-1786.
18. 18 Gilbert RE, Wilkinson-Berka JL, Johnson DW, Cox A, Soulis T, Wu LL, et al. Renal expression of transforming growth factor-β inducible gene-h3 (βig-h3) in normal and diabetic rats. Kidney Int 1998; 54:1052-1062.
19. 19 Ito Y, Aten J, Bende RJ, Oemar BS, Rabelink TJ, Weening JJ, Goldschmeding R. Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 1998; 53:853-861.
20. 20 Abbate M, Benigni A, Bertani T, Remuzzi G. Nephrotoxicity of increased glomerular protein traffic. Nephrol Dial Transplant 1999; 14:304-312.
21. 21 Nangaku M, Pippin J, Couser WG. Complement membrane attack complex (C5b-9) mediates interstitial disease in experimental nephrotic syndrome. J Am Soc Nephrol 1999; 10:2323-2331.
22. 22 Wang YP, Rangan GK, Tay YC, Wang Y, Harris DCH. Induction of monocyte chemoattractant protein-1 by albumin is mediated by nuclear factor kappa B in proximal tubule cells. J Am Soc Nephrol 1999; 10:1204-1213.
23. 23 Zoja C, Donadelli R, Colleoni S, Figliuzzi M, Bonazzola S, Morigi M, Remuzzi G. Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation. Kidney Int 1998; 53:1608-1615. This study demonstrates the role of NF-κB, a stimulant of both MCP-1 and TGFβ production.
24. 24 Burton CJ, Combe C, Walls J, Harris KPG. Secretion of chemokines and cytokines by human tubular epithelial cells in response to proteins. Nephrol Dial Transplant 1999; 14:2628-2633. Apical exposure of the proximal tubular cells to serum or serum protein fractions as filtered in glomerular disease results in basolateral production of inflammatory mediators. Interestingly, pure albumin or IgG did not produce the same effect.
25. 25 Largo R, Gomez-Garre D, Soto K, Marron B, Blanco J, Gazapo RM, et al. Angiotensin-converting enzyme is upregulated in the proximal tubules of rats with intense proteinuria. Hypertension 1999; 33:732-739.
26. 26 Gilbert RE, Wu LL, Kelly DJ, Cox A, Wilkinson JL, Johnston CI, Cooper ME. Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Am J Pathol 1999; 155:429-440. The demonstration of an intrarenal tubular renin angiotensin system.
27. 27 Wolf G. Molecular mechanisms of angiotensin II in the kidney: emerging role in the progression of renal disease: beyond haemodynamics. Nephrol Dial Transplant 1998; 13:1131-1142. A review of the multifunctional actions of angiotensin and their tubulointerstitial implications.
28. 28 Cordonnier DJ, Pinel N, Barro C, Maynard C, Zaoui P, Halimi S, et al. Expansion of the cortical interstitium is limited by converting enzyme inhibition in type 2 iabetic patients with glomerulosclerosis. J Am Soc Nephrol 1999; 10:1253-1263. A study in which the progression of interstitial fibrosis is used as an endpoint to demonstrate a protective effect of ACE inhibitors in type 2 diabetic patients with glomerulosclerosis.
29. 29 Wuthrich RP. The complex role of osteopontin in renal disease. Nephrol Dial Transplant 1998; 13:2448-2450.
30. 30 Lan HY, Yu XQ, Yang N, Nikolic-Paterson DJ, Mu W, Pichler R, et al. De novo glomerular osteopontin expression in rat crescentic glomerulonephritis. Kidney Int 1998; 53:136-145.
31. 31 Abbate M, Zoja C, Corna D, Capitanio M, Bertani T, Remuzzi G. In progessive nephropathies, overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation. J Am Soc Nephrol 1998; 9:1213-1224. Albumin and IgG accumulate in the proximal tubular cells of animals with 5/6 renal ablation or passive Heyman nephritis, with associated osteopontin expression and adjacent interstitial MHC-II-positive cell and macrophage infiltration.
32. 32 Gibbs SR, Goins RA, Belvin EL, DiMari SJ, Merriam AP, Bowling-Brown S, et al. Characterisation of the collagen phenotype of rabbit proximal tubule cells in culture. Connect Tissue Res 1999; 40:173-188.
33. 33 Ng Y-Y, Huang T-P, Yang W-C, Chen Z-P, Yang A-H, Mu W, et al. Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int 1998; 54:864-876. This study supports the concept of tubular epithelial cells transdifferentiating into myofibroblasts.
34. 34 Fan J-M, Ng Y-Y, Hill PA, Nikolic-Paterson D, Mu W, Atkins RC, Lan H-Y. Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int 1999; 56:1455-1467.
35. 35 Wiggins R, Goyal M, Merritt S, Killen PD. Vascular adventitial cell expression of collagen I messenger ribonucleic acid in anti-glomerular basement membrane antibody induced crescentic nephritis in the rabbit. A cellular source for interstitial collagen synthesis in inflammatory renal disease. Lab Invest 1993; 68:557-565.
36. 36 Goumenos D, Tsomi K, Iatrou C, Oldroyd S, Sungur A, Papaioannides D, et al. Myofibroblasts and the progression of crescentic glomerulonephritis. Nephrol Dial Transplant 1999; 13:1652-1661.
37. 37 Oba S, Kimura K, Suzuki N, Mise N, Tojo A, Miyashita K, et al. Relevance of periglomerular myofibroblasts in progression of human glomerulonephritis. Am J Kidney Dis 1998; 32:419-425.
38. 38 Hewitson TD, Darby IA, Bisucci T, Jones CL, Becker GJ. Evolution of tubulointerstitial fibrosis in experimental renal infection and scarring. J Am Soc Nephrol 1998; 9:632-642. A reminder that scarred kidneys have less tubular volume and hence increased matrix density.
39. 39 Schelling JR, Nkemere N, Kopp JB, Cleveland RP. Fas-dependent fractricidal apoptosis is a mechanism of tubular epithelial deletion in chronic renal failure. J Clin Invest 1998; 78:813-824.
40. 40 Thomas ME, Brunskill NJ, Harris KPG, Bailey E, Pringle JH, Furness PN, Walls J. Proteinuria induces tubular cell turnover: a potential mechanism for tubular atrophy. Kidney Int 1999; 55:890-898.
41. 41 Khan S, Cleveland RP, Koch CJ, Schelling JR. Hypoxia induces renal tubular epithelial cell apoptosis in chronic renal disease. Lab Invest 1999; 79:1089-1099. A study colocalizing renal tubule apoptosis to hypoxic but not normal tubules, indicating that tubule cell loss may result from hypoxia-driven apoptosis.
42. 42 Schelling JR, Cleveland RP. Involvement of Fas-dependent apoptosis in renal tubular epithelial deletion in chronic renal failure. Kidney Int 1999; 56:1313-1316.
43. 43 Hughes J, Johnson RJ. Role of Fas (CD95) in tubulointerstitial disease induced by unilateral ureteric obstruction. Am J Physiol 1999; 277:F26-F32.
44. 44 Kelynack KJ, Hewitson TD, Pedagogos E, Nicholls KM, Becker GJ. Renal myofibroblasts contract collagen I lattices in vitro. Am J Nephrol 1999; 19:694-701. A demonstration of the ability of renal myofibroblasts to contract and reorganize surrounding extracellular matrix.
45. 45 Tesch GH, Schwarting A, Kinoshita K, Lan HY, Rollins BJ, Kelley VR. Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis. J Clin Invest 1999; 103:73-80. The genetic deletion of MCP-1 protects against tubular but not glomerular injury in a mouse model of nephrotoxic serum nephritis.
46. 46 Ehara T, Shigematsu H. Contribution of mast cells to the tubulointerstitial lesions in IgA nephritis. Kidney Int 1998; 54:1675-1683.
47. 47 Han DC, Isono M, Hoffman BB, Ziyadeh FN. High glucose stimulates proliferation and collagen I synthesis in renal cortical fibroblasts: mediation by autocrine activation of TGFbeta. J Am Soc Nephrol 1999; 10:1891-1899. A study of potential interest in diabetic progression.
48. 48 Ruiz-Ortega M, Egido J. Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts. Kidney Int 1997; 52:1497-1510.
49. 49 Hogaboam CM, Steinhauser ML, Chensue SW, Kunkel SL. Novel roles for chemokines and fibroblasts in interstitial fibrosis. Kidney Int 1999; 54:2152-2159.
50. 50 Giancotti FG, Ruoslahti E. Integrin signalling. Science 1999; 285:1028-1032.
51. 51 Serini G, Bochaton-Piallet M, Ropraz P, Geinoz A, Borsi L, Zardi L, Gabbiani G. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol 1999; 142:873-881.
52. 52 Lewis MP, Fine LG, Norman JT. Pexicrine effects of basement membrane components on paracrine signaling by renal tubular cells. Kidney Int 1996; 49:48-58.
53. 53 Clayton A, Steadman R, Williams JD. Cells isolated from the human cortical interstitium resemble myofibroblasts and bind neutrophils in an ICAM-1 dependent manner. J Am Soc Nephrol 1997; 8:604-615.
54. 54 Sommer M, Schaller R, Funfstuck R, Bohle A, Bohmer FD, Muller GA, Stein G. Abnormal growth and clonal proliferation of fibroblasts in an animal model of unilateral ureteral obstruction. Nephron 1999; 82:39-50.
55. 55 Johnson DW, Saunders HJ, Field MJ, Pollock CA. In-vitro effects of simvastatin on tubulointerstitial cells in a human model of cyclosporin nephrotoxicity. Am J Physiol 1999; 276:F467-F475.
56. 56 Dugina V, Alexandrova A, Chaponnier C, Vasiliev J, Gabbiani G. Rat fibroblasts cultured from various organs exhibit differences in alpha-smooth muscle actin expression, cytoskeletal pattern, and adhesive structure organization. Exp Cell Res 1999; 238:481-490.
57. 57 Hewitson TD, Martic M, Kelynack K, Pedagogos E, Becker GJ. Pentoxifylline reduces in vitro renal myofibroblast proliferation and collagen secretion. Am J Nephrol 2000; 20:82-88.
58. 58 Rodemann HP, Müller GA. Characterization of human renal fibroblasts in health and disease: II. In vitro growth, differentiation, and collagen synthesis of fibroblasts from kidneys with interstitial fibrosis. Am J Kidney Dis 1991; 17:684-666.
59. 59 Becker GJ, Hewitson TD. The interstitium in renal disease. J Int Med 1997; 242:93-97.
60. 60 Hewitson T, Wu H, Becker G. Interstitial myofibroblasts in experimental renal infection and scarring. Am J Nephrol 1995; 15:411-417.
61. 61 Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Tomaszewski J, Neilson EG. Identification and characterisation of a fibroblast marker FSP1. J Cell Biol 1995; 130:393-405.
62. 62 Fern RJ, Yesko CM, Thornhill BA. Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice. J Clin Invest 1999; 103:30-46.
63. 63 Fukagawa M, Noda M, Shimizu T, Kurokawa K. Chronic progressive interstitial fibrosis in renal disease - are there novel pharmacological approaches? Nephrol Dial Transplant 1999; 14:2793-2795.
64. 64 Benigni A, Remuzzi G. Endothelin receptor antagonists: which are the therapeutic perspectives in renal diseases? Nephrol Dial Transplant 1998; 13:5-7.
65. 65 Forbes JM, Leaker B, Hewitson TD, Becker GJ, Jones CL Macrophage and myofibroblast involvement in ischemic acute renal failure is attenuated by endothelin receptor antagonists. Kidney Int 1999; 55:198-208.
66. 66 Shimizu T, Kuroda T, Hata S, Fukagawa M, Margolin SB, Kurokawa K. Pirfenidone improves renal function and fibrosis in the post-obstructed kidney. Kidney Int 1998; 54:99-109. This study demonstrates that pirfenidone can normalize the over-expression of collagen production after unilateral ureteric obstruction.